Assertio (ASRT) Short Interest Ratio & Short Volume $1.09 -0.04 (-3.54%) (As of 12/8/2023 ET) Add Compare Share Share Today's Range$1.09▼$1.1650-Day Range$1.02▼$2.5752-Week Range$0.87▼$8.01Volume812,361 shsAverage Volume1.97 million shsMarket Capitalization$103.19 millionP/E RatioN/ADividend YieldN/APrice Target$5.50 Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Assertio Short Interest DataCurrent Short Volume8,670,000 sharesPrevious Short Volume8,440,000 sharesChange Vs. Previous Month+2.73%Dollar Volume Sold Short$9.88 millionShort Interest Ratio / Days to Cover5.1Last Record DateNovember 15, 2023Outstanding Shares94,669,000 sharesPercentage of Shares Shorted9.16%Today's Trading Volume812,361 sharesAverage Trading Volume1,967,028 sharesToday's Volume Vs. Average41% Short Selling Assertio ? Sign up to receive the latest short interest report for Assertio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatASRT Short Interest Over TimeASRT Days to Cover Over TimeASRT Percentage of Float Shorted Over Time Assertio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/15/20238,670,000 shares $9.88 million +2.7%N/A5.1 $1.14 10/31/20238,440,000 shares $18.15 million +3.1%N/A5.7 $2.15 10/15/20238,190,000 shares $19.16 million -7.0%N/A3.7 $2.34 9/30/20238,810,000 shares $22.55 million -2.7%N/A4 $2.56 9/15/20239,050,000 shares $24.93 million -2.7%N/A4 $2.76 8/31/20239,300,000 shares $30.50 million +1.2%N/A4.1 $3.28 Get the Latest News and Ratings for ASRT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Assertio and its competitors with MarketBeat's FREE daily newsletter. 8/15/20239,190,000 shares $29.59 million -14.4%N/A4.2 $3.22 7/31/202310,730,000 shares $61.05 million +0.9%N/A4.6 $5.69 7/15/202310,630,000 shares $54.74 million -3.5%N/A5.5 $5.15 6/30/202311,010,000 shares $59.67 million +7.6%N/A5.5 $5.42 6/15/202310,230,000 shares $62.81 million +0.6%N/A4.9 $6.14 5/31/202310,170,000 shares $64.38 million +2.6%N/A4.8 $6.33 5/15/20239,910,000 shares $72.54 million +3.3%N/A4 $7.32 4/30/20239,590,000 shares $52.84 million -1.3%N/A4 $5.51 4/15/20239,720,000 shares $61.14 million +8.7%N/A4.8 $6.29 3/31/20238,940,000 shares $56.95 million +5.7%N/A4.5 $6.37 3/15/20238,460,000 shares $48.05 million +57.8%N/A4.6 $5.68 2/28/20235,360,000 shares $29.64 million -43.2%N/A3.4 $5.53 2/15/20239,440,000 shares $48.14 million +12.0%N/A7.4 $5.10 1/31/20238,430,000 shares $34.65 million +8.2%N/A7.9 $4.11 1/15/20237,790,000 shares $32.64 million +4.9%N/A8.1 $4.19 12/30/20227,430,000 shares $31.95 million +14.0%N/A9 $4.30 12/15/20226,520,000 shares $23.73 million +11.5%N/A8.3 $3.64 11/30/20225,850,000 shares $18.14 million -0.5%N/A8.3 $3.10 11/15/20225,880,000 shares $17.29 million +2.6%N/A7.2 $2.94 10/31/20225,730,000 shares $14.78 million -1.4%N/A6.1 $2.58 10/15/20225,810,000 shares $12.67 million -2.5%N/A5.5 $2.18 9/30/20225,960,000 shares $13.53 million +2.4%N/A5.3 $2.27 9/15/20225,820,000 shares $14.20 million +29.6%N/A4.7 $2.44 8/31/20224,490,000 shares $11.45 million +509.7%N/A3.7 $2.55 8/15/2022736,400 shares $2.72 million +2.6%N/A0.6 $3.70 7/31/2022718,100 shares $2.80 million -23.9%N/A0.7 $3.90 7/15/2022943,600 shares $2.66 million +9.4%N/A1 $2.82 6/30/2022862,500 shares $2.54 million +6.1%N/A0.9 $2.95 6/15/2022813,200 shares $2.29 million +2.3%N/A0.8 $2.82 5/31/2022795,300 shares $2.39 million -19.4%N/A0.8 $3.01 5/15/2022987,200 shares $2.82 million +68.8%N/A1.1 $2.86 4/30/2022584,700 shares $1.23 million -27.4%N/A0.7 $2.11 4/15/2022805,400 shares $2.38 million -1.0%N/A0.9 $2.95 3/31/2022813,400 shares $2.33 million +57.9%N/A0.9 $2.87 ASRT Short Interest - Frequently Asked Questions What is Assertio's current short interest? Short interest is the volume of Assertio shares that have been sold short but have not yet been closed out or covered. As of November 15th, traders have sold 8,670,000 shares of ASRT short. Learn More on Assertio's current short interest. What is a good short interest ratio for Assertio? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ASRT shares currently have a short interest ratio of 5.0. Learn More on Assertio's short interest ratio. Which institutional investors are shorting Assertio? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Assertio: Wolverine Asset Management LLC, UBS Group AG, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Assertio's short interest increasing or decreasing? Assertio saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 8,670,000 shares, an increase of 2.7% from the previous total of 8,440,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Assertio's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Assertio: GlycoMimetics, Inc. (1.36%), Annovis Bio, Inc. (6.88%), Kinnate Biopharma Inc. (5.38%), 2seventy bio, Inc. (26.17%), Milestone Pharmaceuticals Inc. (1.15%), BioXcel Therapeutics, Inc. (25.12%), Oncolytics Biotech Inc. (2.03%), Vaxxinity, Inc. (11.63%), Organigram Holdings Inc. (6.40%), Capricor Therapeutics Inc (4.42%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: RTX Co. ($7.24 billion), T-Mobile US, Inc. ($4.02 billion), Charter Communications, Inc. ($3.72 billion), Occidental Petroleum Co. ($2.80 billion), Lululemon Athletica Inc. ($2.48 billion), Coinbase Global, Inc. ($2.38 billion), Tractor Supply ($2.35 billion), Rivian Automotive, Inc. ($1.79 billion), Royal Caribbean Cruises Ltd. ($1.73 billion), and Moderna, Inc. ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Assertio stock? Short selling ASRT is an investing strategy that aims to generate trading profit from Assertio as its price is falling. ASRT shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Assertio? A short squeeze for Assertio occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ASRT, which in turn drives the price of the stock up even further. How often is Assertio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ASRT, twice per month. The most recent reporting period available is November, 15 2023. More Short Interest Resources from MarketBeat Related Companies: GlycoMimetics Short Squeeze Annovis Bio Short Squeeze Kinnate Biopharma Short Squeeze 2seventy bio Short Squeeze Milestone Pharmaceuticals Short Squeeze BioXcel Therapeutics Short Squeeze Oncolytics Biotech Short Squeeze Vaxxinity Short Squeeze Organigram Short Squeeze Capricor Therapeutics Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ASRT) was last updated on 12/9/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Assertio Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.